OVERVIEW

Examining the Application of Immunoglobulin in Multiple Disease States: A Review of Evidence is organized by Pharmacy Times Continuing Education (PTCE).

Dates:-
Start Date:- Jun 17, 2019
End Date:- Jun 26, 2020.

Target Audience:
Pharmacists and managed care professionals

Accreditation:
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEUs)

Course Description:
The administration of immunoglobulin (Ig) has become common practice in the treatment of patients with immunodeficiencies, and, more recently, in other disorders, including inflammatory diseases and autoimmune neuropathies. Patients with these disorders experience significant morbidity and mortality, and the often life-altering consequences of these diseases can also have substantial direct and indirect costs accounting for billions of dollars impacting the US economy. With the continual research into the genetic basis of disease, more data will be forthcoming on the evolving use of Ig in patients with genetic abnormalities. Healthcare professionals require proper training and foundational knowledge on best practices for the use of Ig agents to provide patients with clinically appropriate and cost-effective individualized options for therapy that will improve treatment outcomes and overall quality of life.

Educational Objectives:
At the completion of this activity, the participant will be able to:
• Examine the evidence that supports the use of immunoglobulin (Ig) for immune deficiency and autoimmune diseases.
• Differentiate the characteristics and value of intravenous and subcutaneous administration of Ig for individualized treatment.
• Evaluate healthcare utilization economics of patients using Ig treatments in inpatient and outpatient settings.

Additional details will be posted as soon as information is available.